Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 2)

v3.8.0.1
Stockholders' Equity (Details 2) - Warrant [Member]
3 Months Ended
Sep. 30, 2017
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Number of Shares, Outstanding and vested | shares 3,886,866
Number of Shares, Granted | shares 3,384,666
Number of Shares, Exercised | shares (16,770)
Number of Shares, Outstanding and vested | shares 7,254,762
Weighted Average Exercise Price Per Share, Outstanding and vested | $ / shares $ 7.71
Weighted Average Exercise Price Per Share, Granted | $ / shares 1.52
Weighted Average Exercise Price Per Share, Exercised | $ / shares
Weighted Average Exercise Price Per Share, Outstanding and vested | $ / shares $ 4.81
Weighted Average Remaining Contractual Term (Years), Outstanding 2 years 4 months 24 days
Weighted Average Remaining Contractual Term (Years), Granted 6 years 10 months 25 days
Weighted Average Remaining Contractual Term (Years), Exercised 4 years 4 months 24 days